Related references
Note: Only part of the references are listed.Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
Aline Vidal Lacerda Gontijo et al.
CURRENT MICROBIOLOGY (2022)
Identification of a novel plasmid-mediated tigecycline resistance-related gene, tet(Y), in Acinetobacter baumannii
Zhiren Wang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Phage φAB6-Borne Depolymerase Combats Acinetobacter baumannii Biofilm Formation and Infection
Md. Shahed-Al-Mahmud et al.
ANTIBIOTICS-BASEL (2021)
An Outbreak of tet(X6)-Carrying Tigecycline-Resistant Acinetobacter baumannii Isolates with a New Capsular Type at a Hospital in Taiwan
Yu-Chia Hsieh et al.
ANTIBIOTICS-BASEL (2021)
Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii
Stamatis Karakonstantis et al.
ANTIBIOTICS-BASEL (2021)
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists
Jacinda C. Abdul-Mutakabbir et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Ioannis Kyriakidis et al.
PATHOGENS (2021)
Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
Jeongwoo Jo et al.
MICROBIOLOGY SPECTRUM (2021)
CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies
Manuel Gonzalez de Aledo et al.
ANTIBIOTICS-BASEL (2021)
Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf
Xiaoting Hua et al.
EMERGING MICROBES & INFECTIONS (2021)
Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii
Helal F. Hetta et al.
SCIENTIFIC REPORTS (2021)
Evaluation of Tigecycline and Minocycline Susceptibility among Clinical Isolates of Carbapenem Resistant Acinetobacter Species
Asna Parveen et al.
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS (2021)
Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate
Liyuan Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters
Wuen Ee Foong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans
Ina Gajic et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2020)
A Cyclic-di-GMP signalling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978
Irfan Ahmad et al.
SCIENTIFIC REPORTS (2020)
The distribution of mutations and hotspots in transcription regulators of resistance-nodulation-cell division efflux pumps in tigecycline non-susceptible Acinetobacter baumannii in China
Qingye Xu et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens
Daniel V. Zurawski et al.
ANTIBIOTICS-BASEL (2020)
Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen
Carole Ayoub Moubareck et al.
ANTIBIOTICS-BASEL (2020)
Dynamics of a Sporadic Nosocomial Acinetobacter calcoaceticus - Acinetobacter baumannii Complex Population
Pilar Villalon et al.
FRONTIERS IN MICROBIOLOGY (2019)
Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans
Tao He et al.
NATURE MICROBIOLOGY (2019)
Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii
Natalia Baginska et al.
VIROLOGICA SINICA (2019)
Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii
Qingye Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The Mechanisms of Disease Caused by Acinetobacter baumannii
Faye C. Morris et al.
FRONTIERS IN MICROBIOLOGY (2019)
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Burcu Isler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii
Jennifer K. Singh et al.
FRONTIERS IN MICROBIOLOGY (2019)
Tocopherol polyethylene glycol succinate-modified hollow silver nanoparticles for combating bacteria-resistance
Xu-Qi Kang et al.
BIOMATERIALS SCIENCE (2019)
Accurate identification of clinically important Acinetobacter spp.: an update
Saranya Vijayakumar et al.
FUTURE SCIENCE OA (2019)
Diversity of mutations in regulatory genes of resistance-nodulationcell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii
Stefanie Gerson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Multidrug efflux pumps: structure, function and regulation
Dijun Du et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii
Mathias Jansen et al.
SCIENTIFIC REPORTS (2018)
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
Travis B. Nielsen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance
Ming-Feng Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2017)
New eight genes identified at the clinical multidrug-resistant Acinetobacter baumannii DMS06669 strain in a Vietnam hospital
Nguyen Si-Tuan et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
Chang-Ro Lee et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism
Vincent Trebosc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii
X. Li et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients
Constantinos Tsioutis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains
Agnieszka Chmielarczyk et al.
MICROBIAL DRUG RESISTANCE (2016)
The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
Kathryn Beabout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii
Chui-Yoke Chin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates
Henan Li et al.
FUTURE MICROBIOLOGY (2015)
AbuO, a TolC-Like Outer Membrane Protein of Acinetobacter baumannii, Is Involved in Antimicrobial and Oxidative Stress Resistance
Vijaya Bharathi Srinivasan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase
X. Li et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance
Troy G. Hammerstrom et al.
PLOS ONE (2015)
Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital
Mei Deng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility
Ming-Feng Lin et al.
BMC MICROBIOLOGY (2014)
Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase
Qiong Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Antibiotic susceptibility and molecular epidemiology of Acinetobacter calcoaceticus-baurnannii complex strains isolated from a referral hospital in northern Vietnam
Trang Dinh Van et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2014)
Antimicrobial resistance in Acinetobacter baumannii : From bench to bedside
Ming-Feng Lin et al.
WORLD JOURNAL OF CLINICAL CASES (2014)
RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations
Eun-Jeong Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii
C. Rumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Tigecycline: an update
Gary E. Stein et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Acinetobacter baumannii Strain M2 Produces Type IV Pili Which Play a Role in Natural Transformation and Twitching Motility but Not Surface-Associated Motility
Christian M. Harding et al.
MBIO (2013)
Expression of the Resistance-Nodulation-Cell Division Pump AdeIJK in Acinetobacter baumannii Is Regulated by AdeN, a TetR-Type Regulator
Nicolas Rosenfeld et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A Truncated AdeS Kinase Protein Generated by ISAba1 Insertion Correlates with Tigecycline Resistance in Acinetobacter baumannii
Jun-Ren Sun et al.
PLOS ONE (2012)
Acinetobacter baumannii An emerging opportunistic pathogen
Aoife Howard et al.
VIRULENCE (2012)
Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy
Michael Hornsey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Overexpression of the adeB Gene in Clinical Isolates of Tigecycline-Nonsusceptible Acinetobacter baumannii without Insertion Mutations in adeRS
Jun-Ren Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
Sebastien Coyne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009)
Rodrigo E. Mendes et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Isolation and characterization of φAB2: a novel bacteriophage of Acinetobacter baumannii
Nien-Tsung Lin et al.
RESEARCH IN MICROBIOLOGY (2010)
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii
Anton Y. Peleg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Tigecycline is modified by the flavin-dependent monooxygenase TetX
IF Moore et al.
BIOCHEMISTRY (2005)
Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii
A Ribera et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Share Paper
